Price band: ₹960 to ₹1008 per share.
Initial investment: ₹2.18 crore. Thapar holds 6,339,800 shares at a cost of ₹3.44 each. Selling 1,268,600 shares in the OFS.
Mehta holds 75,816,748 shares (41.85%). Selling up to 420,000 shares in the OFS. Expected 52x return at the upper price band.
BC Investments IV will gain 3.63x. A significant profit is expected from their stake in Emcure Pharmaceuticals.
Other promoters offloading shares. Includes Pushpa Mehta, Bhavana Mehta, Kamini Mehta, Arunkumar Khanna, Berjis Desai, and Sonali Mehta.
IPO: ₹800 crore fresh issue + OFS. A total of 1.14 crore equity shares are being offered by existing shareholders, including promoters.